5,081 Shares in Danaher Corporation $DHR Bought by Perigon Wealth Management LLC

Perigon Wealth Management LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,081 shares of the conglomerate’s stock, valued at approximately $968,000.

Several other institutional investors have also bought and sold shares of the business. Northwestern Mutual Wealth Management Co. grew its holdings in Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Legal & General Group Plc lifted its stake in Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after purchasing an additional 43,169 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Danaher by 51.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock worth $62,205,000 after purchasing an additional 92,323 shares during the last quarter. Advisors Capital Management LLC boosted its position in shares of Danaher by 14.0% during the fourth quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after buying an additional 6,720 shares during the period. Finally, Handelsbanken Fonder AB grew its stake in shares of Danaher by 10.9% during the second quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after buying an additional 28,425 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.5%

Shares of NYSE DHR opened at $199.62 on Wednesday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market capitalization of $140.33 billion, a price-to-earnings ratio of 35.46, a PEG ratio of 2.52 and a beta of 0.78. The stock has a 50 day moving average price of $193.74 and a 200 day moving average price of $192.50. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the business posted $0.77 EPS. Sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on DHR shares. DZ Bank initiated coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. Royal Bank Of Canada upped their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. UBS Group reduced their target price on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. lowered their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.